Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 20NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Breast Neoplasms 32Central Nervous System Neoplasms 30Carcinoma, Non-Small-Cell Lung 28Lung Neoplasms 27Head and Neck Neoplasms 26Glioblastoma 25Leukemia 24Squamous Cell Carcinoma of Head and Neck 22Lymphoma 22Gliosarcoma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Sarcoma 17Astrocytoma 17Burkitt Lymphoma 14Pancreatic Neoplasms 13Rectal Neoplasms 12Lymphoma, Large B-Cell, Diffuse 12Uterine Cervical Neoplasms 11Neuroblastoma 11Lymphoma, Follicular 10Adenocarcinoma of Lung 10Lymphoma, Non-Hodgkin 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Acute 9Esophageal Neoplasms 9Brain Neoplasms 9Lymphoma, Mantle-Cell 8Lymphoma, B-Cell, Marginal Zone 8Laryngeal Neoplasms 8Hodgkin Disease 8

Interventions

fludarabine phosphate 6Cytarabine 6Peripheral Blood Stem Cell Transplantation 4Etoposide 4Busulfan 4Hydroxyurea 3Filgrastim 3Decitabine 3Cyclophosphamide 3romidepsin 2laromustine 2Vorinostat 2Tretinoin 2Sunitinib 2Radiotherapy 2Methotrexate 2Ipilimumab 2Idarubicin 2Daunorubicin 2CTLA-4 Antigen 2Antilymphocyte Serum 2Analgesia 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2veliparib 1valspodar 1tipifarnib 1perifosine 1gamma-Globulins 1belinostat 1aflibercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Radiotherapy × Clear all
NCT00025402 2013-12-18

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
1,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡